Molecular simulations reveal transport mechanisms of serotonin and dopamine by VMAT2, indicating implications for treating neurological disorders.
Filling synaptic vesicles with neurotransmitters is essential in biology, as it is required for nerve signaling across a chemical synapse and for the safe storage of otherwise toxic neurotransmitters. Vesicular monoamine transporter 2 (VMAT2) uses a proton gradient to pump serotonin, dopamine, norepinephrine, and histamine into synaptic vesicles in the brain. Despite VMAT2's critical roles in biology and as a drug target, the atomic-level mechanisms by which VMAT2 performs proton-coupled neurotransmitter transport have remained unclear. To determine these mechanisms, we combine molecular simulations based on classical physics (to observe large-scale conformational transitions) with those based on quantum mechanics (to observe proton transfer reactions). This work addresses a crucial knowledge gap in basic science and informs drug discovery for neurological and neuropsychiatric disorders.
No takes yet. Share an insight, caveat, or question.
Carl‐Mikael Suomivuori (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: